Advik Laboratories Ltd — Important, 20-01-2026: Company Update

MPS Pharmaa Limited has reported on investor complaints for the recent quarter. The company stated that there were no investor complaints pending at the beginning of the quarter, none were received, and consequently, no complaints remained unresolved by the quarter's end. This indicates efficient investor grievance handling and a smooth quarter for stakeholder interactions, reflecting positively on investor relations.